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Background: Continuous diabetes-associated complications are a major source of immune system exhaustion and
an increased incidence of infection. Diabetes can cause poor circulation in the feet, increasing the likelihood of
ulcers forming when the skin is damaged and slowing the healing of the ulcers. Whey proteins (WPs) enhance
immunity during childhood and have a protective effect on some immune disorders. Therefore, in this study, we
investigated the effects of camel WP on the healing and closure of diabetic wounds in a streptozotocin (STZ)-
induced type I diabetic mouse model.
Results: Diabetic mice exhibited delayed wound closure characterized by a significant decrease in an anti-
inflammatory cytokine (namely, IL-10) and a prolonged elevation of the levels of inflammatory cytokines (TNF-α, IL-
1β and IL-6) in wound tissue. Moreover, aberrant expression of chemokines that regulate wound healing (MIP-1α,
MIP-2, KC and CX3CL1) and growth factors (TGF-β) were observed in the wound tissue of diabetic mice compared
with control nondiabetic mice. Interestingly, compared with untreated diabetic mice, supplementation with WP
significantly accelerated the closure of diabetic wounds by limiting inflammatory stimuli via the restoration of
normal IL-10, TNF-α, IL-1β and IL-6 levels. Most importantly, the supplementation of diabetic mice with WP
significantly modulated the expression of MIP-1α, MIP-2, KC, CX3CL1 and TGF-β in wound tissue compared with
untreated diabetic mice.
Conclusion: Our data demonstrate the benefits of WP supplementation for improving the healing and closure of
diabetic wounds and restoring the immune response in diabetic mice.
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Type I diabetes (T1D) is a chronic autoimmune disease
caused by the specific destruction of pancreatic β-cells,
which produce insulin [1], Multiple complications are
usually associated with diabetes mellitus [2]. Impaired
wound healing represents a severe complication of the
disease, which could diminish physical activity and lead* Correspondence: badr73@yahoo.com
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reproduction in any medium, provided the orto chronic wounds and limb amputation [3]. Previous
studies have reported that wound healing involves a
complex series of interactions between different cell
types, cytokine mediators, and the extracellular matrix.
The phases of normal wound healing include hemo-
stasis, inflammation, proliferation, and remodeling [4].
Moreover, many factors that can affect wound healing
interfere with one or more phases in this process, thus
causing improper or impaired tissue repair. For instance,
collagen deposition in acute wounds is impaired in T1D;
possibly due to a decreased fibroblast proliferation [5].
The capacity of a wound to heal depends in part on its
depth, as well as on the overall health and nutritionald. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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IL-1β, IL-6, and TNF-α are thought to play important
roles in wound repair, including the stimulation of kera-
tinocyte and fibroblast proliferation, the synthesis and
breakdown of extracellular matrix proteins, fibroblast
chemotaxis, and immune response regulation [7]. Dia-
betic individuals are more susceptible to both wound
infection and hyper-inflammation, which cannot be
pathogenically separated from the elevated levels of pro-
inflammatory cytokines, such as TNF-α and IL-6 [8].
In addition, TNF-α dysregulation in mouse model of
diabetic wounds impairs healing, which may involve
the enhanced apoptosis and decreased proliferation of
fibroblasts [9]. Moreover, overexpression of IL-10, an
anti-inflammatory cytokine, decreases the inflammatory
response to injury, creating an environment conducive
for regenerative adult wound healing [10]. Several che-
mokines that have been identified as regulators of spe-
cific leukocyte accumulation at wound sites [11], such as
macrophage inflammatory proteins 1α and 2 (MIP-1α,
MIP-2), are major chemoattractants for monocytes/
macrophages and play key roles in macrophage infiltration
during wound healing [12]. In particular, keratinocyte-
derived chemokine (KC) and MIP-2 are believed to par-
ticipate in the recruitment of neutrophils to sites of
inflammation in many tissues [13]. CX3CL1 is expressed
as a soluble chemokine and as a membrane-bound form
on the surface of inflamed endothelial cells, epithelial cells,
macrophages, and vascular smooth muscle cells. The che-
mokine CX3CL1 and its receptor CX3CR1 are both highly
induced at wound sites and mediate skin wound healing
by promoting macrophage and fibroblast accumulation
and function [14]. Although CX3CL1 directly stimulates
angiogenesis, the local microvasculature also depends
on several other growth factors, including transforming
growth factor-β (TGF-β), which is produced by macro-
phages in wounds [15] and functions in leukocyte chemo-
taxis, fibroblast and smooth muscle cell mitogenesis and
extracellular matrix deposition during granulation tissue
formation [16].
Protein is essential for the maintenance and repair of
body tissue. Depleted protein levels cause a decrease
in collagen development, slowing the wound healing
process. Adequate protein levels help to achieve optimal
wound healing rates [17]. Camel whey proteins (WPs)
are composed of a heterogeneous group of proteins that
include serum albumin, α lactalbumin, immunoglobulin,
lactophorin and peptidoglycan recognition protein [18].
Dietary whey supplementation is thought to increase
glutathione synthesis and cellular antioxidant defense
[19]. Therefore, WP may be a therapeutic tool for oxida-
tive stress-associated diseases [20]. In addition to its
immunomodulatory properties and its ability to boost
the host defense systems [21], WP fractions are linked toa range of bioactive functions, such as prebiotic effects,
the promotion of tissue repair, the maintenance of intes-
tinal integrity, the destruction of pathogens and the
elimination of toxins [22]. In addition, a clear modula-
tion of immune functions by several whey protein-
derived products has been demonstrated in vitro and
in vivo [23]. Our recent published study revealed that
the supplementation of diabetic mice with WP rescued
functional, long-lived wound-resident macrophages and
improved the healing and closure of diabetic wounds
[24]. Additionally, it was found that dietary supplemen-
tation with WP enhances the normal inflammatory
responses during wound healing in diabetic mice by
restoring the levels of oxidative stress and inflammatory
cytokines [25]. Recent studies have shown that whey
increases antioxidant activity in the body, combats
fatigue and inflammation, hastens healing, improves
stamina and may discourage related infections because
of the immune system-enhancing and natural antibiotic
properties of its components [26,27]. Nevertheless, there
are few studies that have investigated the influence
of WPs in wound healing. The aim of this study was to
investigate the potential modulatory effects of the oral
administration of WPs on wound healing using a dia-
betic mouse model.
Methods
Preparation of whey proteins
Raw camel milk was collected from healthy female
camels (Majaheim) from the Riyadh area in Saudi Ara-
bia. The milk was then centrifuged to remove the cream.
The obtained skim milk was acidified to pH 4.3 using
1 N HCl at room temperature and centrifuged at 10,000
x g for 10 min to precipitate the casein. The resulting
whey, which contained the whey proteins, was saturated
with ammonium sulfate to a final saturation of 80% to
precipitate the whey proteins. The precipitated whey
proteins were dialyzed against 20 volumes of distilled
water for 48 hr using a molecular porous membrane
with a molecular weight cutoff of 6,000-8,000 kDa. The
dialysate containing undenatured whey proteins was
lyophilized and refrigerated until use.
Chemicals
Streptozotocin (STZ) was obtained from Sigma Chem-
ical Co., St. Louis, MO, USA. STZ was dissolved in cold
0.01 M citrate buffer (pH 4.50) and was always freshly
prepared for immediate use (within 5 min).
Animals and experimental design
A total of 60 sexually mature, 12-week-old male Swiss
Webster (SW) mice, each weighing 25-30 g, were
obtained from the Central Animal House of the Faculty
of Pharmacy at King Saud University. All animal
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dards set forth in the Guidelines for the Care and Use of
Experimental Animals by the Committee for the Purpose
of Control and Supervision of Experiments on Animals
(CPCSEA). The study protocol was approved by the
Animal Ethics Committee of the Zoology Department,
College of Science, King Saud University according
to the Helsinki principles. All animals were allowed to
acclimate to the metal cages inside a well-ventilated
room for 2 weeks prior to experimentation. Animals
were maintained under standard laboratory condi-
tions (temperature 23 °C, relative humidity 60-70% and
a 12-hour light/dark cycle), fed a diet of standard com-
mercial pellets and given water ad libitum. All mice were
fasted for 20 hr prior to diabetes induction. Mice
(n= 40) were rendered diabetic with an intraperitoneal
injection (i.p.) of a single dose of STZ (60 mg/kg body
weight) in 0.01 M citrate buffer (pH 4.5) [28]. Blood glu-
cose levels were measured 3 consecutive days after STZ
injection by cutting off the tip of the tail, squeezing it
gently and using OneTouch Ultra (LifeScan, Paris,
France). Mice were considered diabetic if glycemia was
higher than 220 mg/dl with monitoring initial and final
glycemia during wound healing period (Badr, 2012).
Mice in the control group (n= 20) were injected with
the vehicle alone (0.01 M citrate buffer, pH 4.5). The
animals were divided into three experimental groups:
group 1, control non-diabetic mice that were orally sup-
plemented with distilled water (250 μl/mouse/day for
one month by oral gavage); group 2, diabetic mice that
were orally supplemented with distilled water (250 μl/
mouse/day for one month by oral gavage); and group 3,
diabetic mice orally supplemented with undenatured
WP (100 mg/kg body weight dissolved in 250 μl/day for
one month by oral gavage). Therefore, the supplemented
volume for the 3 groups was constant and did not
exceed 250 μl per dosage. The optimal dose of WP
was determined in our laboratory on the basis of the
LD50 and several established parameters.
Excisional wound preparation and macroscopic examination
Following diabetes induction, mice in each group
(n = 20) were wounded at the age of 12 weeks. Wounded
mice in each group (n = 20) were divided into two sub-
groups (n = 10 in each subgroup). Ten mice were used
for the data presented in this study and the other 10
animals from each group were used for the measure-
ment of hydroxyproline content in the wound sites.
After drying for 24 h at 120 °C, the amount of hydroxy-
proline, a major constituent of collagen in skin wound
sites, was measured to index collagen accumulation at
the wound site. All the diabetic animals in the diabetic
group (n = 20) and in the WP-treated diabetic group
(n = 20) were all responded to STZ and diabetesinduction was confirmed by monitoring the blood glu-
cose levels throughout the experiment period. Wound-
ing of mice was performed as described previously [29].
Briefly, mice were anesthetized with a single i.p. injec-
tion of ketamine (80 mg/kg body weight) and xylazine
(10 mg/kg body weight). Blood samples were immedi-
ately collected from orbital sinus in a non-heparinized
tube and centrifuged for 10 min at 3000 rpm to separate
the serum, then stored at 80 °C and later used to bio-
chemical analyses. The hair on the back of each mouse
was cut, and the back was subsequently cleansed with
70% ethanol. Six full-thickness wounds (5 mm in diam-
eter, 3-4 mm apart) were made on the back of each
mouse by excising the skin and the underlying pannicu-
lus carnosus. The wounds were allowed to form a scab.
Wound closure measurement
Skin biopsy specimens were obtained from the animals
at 4, 7, 10, and 13 days post-injury. At each time point,
an area that included the scab, the complete epithelial
and dermal compartments of the wound margins, the
granulation tissue, and parts of the adjacent muscle and
subcutaneous fat tissue was excised from each individual
wound. Occasionally, a similar amount of skin was taken
from the backs of non-wounded normal mice as a con-
trol. Each wound site was photographed by single cam-
era digital photogrammetry (SCP) at the indicated time
intervals to determine the wound areas. The wound
area was determined by wound measurement software
(VeV MD, Vista Medical, Winnipeg, Manitoba, Canada).
Total surface area yet to be healed was calculated by
the principal investigator who was blinded to group as-
signment. Changes in wound area are expressed as the
percentage of the initial wound area. At the indicated
time points, tissue from two wounds from each of ten
animals (n = 20 wounds) was harvested for RNA analysis,
RT-PCR.
Blood analysis
Blood glucose levels were determined using the Accu-
Trend sensor (Roche Biochemicals, Mannheim, Ger-
many). Serum insulin levels were analyzed by Luminex
(Biotrend, Düsseldorf, Germany) according to the manu-
facturer’s instructions.
Biochemical analysis of wound tissue
Analysis of wound tissue cytokine levels
Wound tissues from 10 mice/group were pulverized
under liquid nitrogen followed by the extraction of
protein as described [30]. The levels of IL-1β, IL-6,
IL-10 and TNF-α in tissue extracts were measured
using commercially available ELISA kits (R&D Sys-
tems, Wiesbaden, Germany) according to the manufac-
turer’s instructions.
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Total RNA was isolated from wounded skin samples
(10 mice/group) using TRIzol reagent (Invitrogen Life
Technologies, France) according to the manufacturer’s
instructions. Before reverse transcription, RNA was trea-
ted with RNase-free DNase I following the manufac-
turer’s protocol. cDNA was synthesized from 3 μg of
total RNA using a Superscript III RT kit (Invitrogen Life
Technologies, France). Unique primer sets for mouse
MIP-1α, MIP-2, KC, CX3CL1, TGF-β1 and β-actin were
designed (Table 1) based on sequences deposited with
the National Center for Biotechnology Information and
were synthesized by Invitrogen Life Technologies. PCR
was performed using 1 μl of cDNA in a reaction mix
with Taq polymerase (Invitrogen Life Technologies).
PCR was found to be linear between 20 and 35 cycles,
and PCR conditions were optimized to allow for a
semiquantitative comparison of results. Bands separated
on ethidium bromide-stained agarose gels were quanti-
tated from digital images using NIH Image Analysis
Software. The intensity of each product was normalized
to the intensity of the β-actin product and expressed
relative to the levels in injured skin from control non-
diabetic mice.
Statistical analysis
Data were first tested for normality (using Anderson–
Darling test) and for variances homogeneity prior to any
further statistical analysis. Data were normally distribu-
ted and were expressed as the mean± standard error of
the mean (SEM). Significant differences among groups
were analyzed using a one- or two-way ANOVA fol-
lowed by Bonferroni’s multiple comparison tests using
PRISM statistical analysis software (GraphPad Software)
and data was reanalyzed using a one- or two-wayTable 1 Sequences of primers used for RT-PCR
Transcript Sequences Product
size (bp)
MIP-1α (F) 5’-GCCCTTGCTGTTCTTCTCTGT-3’ 258
(R) 5’-GGCATTCAGTTCCAGGTCAGT-3’
MIP-2 (F) 5’-GAACAAAGGCAAGGCTAACTGA-3’ 204
(R) 5’-AACATAACAACATCTGGGCAAT-3’
KC (F) 5’-GTGTCCCCAAGTAACGGAGA-3’ 317
(R) 5’-TGCACTTCTTTTCGCACAAC-3’
CX3CLI (F) 5’GTTGGCTCCTGAGAGTGAGG-3’ 301
(R) 5’-CAAAATGGCACAGACATTGG-3’
TGF-β1 (F) 5’-CGGGGCGACCTGGGCACCATCCATGAC-3’ 405
(R) 5’-CTGCTCCACCTTGGGCTTGCGACCCA-3’
β-actin (F) 5’-TTCTACAATGAGCTGCGTGTGGC-3’ 456
(R) 5’-CTCATAGCTCTTCTCCAGGGAGGA
(F), Forward primer; (R), reverse primer.ANOVA followed by Tukey’s post-test using SPSS soft-
ware, version 17. Differences were considered statisti-
cally significant at *P< 0.05, diabetic vs. control;
+P< 0.05, diabetic +WP vs. control; #P< 0.05, diabetic +
WP vs. diabetic.
Results
Administration of camel WP expedites wound closure in
diabetic mice
We evaluated the macroscopic changes at skin-excision
wound sites in control mice, diabetic mice and diabetic
mice supplemented with WP. Pictures were taken on
day 0 immediately after the injury. The wound sites
exhibited a similar morphology in all 3 experimental
groups on day 1 post-injury, and the wounds in the con-
trol and diabetic mice supplemented with WP were
similarly closed at 13 days post-injury. By contrast, the
diabetic mice exhibited delayed wound closure. Changes
in the diameters of wounded area throughout the experi-
ment period were monitored in the 3 groups. Accumu-
lated data from 10 individual mice in each group is
expressed as the mean percentage of wound closure ±
SEM at each time point Figure 1. These results demon-
strate that wound closure and healing were accelerated
in the diabetic mice supplemented with camel WP com-
pared with untreated diabetic mice, which exhibited
delayed wound closure. To optimize the parameters and
conditions of the animal models during the experiments,
blood glucose and insulin levels in the 3 groups of mice
were monitored before and throughout the indicated
time points post-injury (Table 2). Glucose levels in the
WP-treated diabetic group were significantly lower
than in the diabetic group and were higher than in the
control group. By contrast, insulin levels were signifi-
cantly increased in the WP-treated diabetic groupFigure 1 Macroscopic changes at skin excisional wound sites.
Changes in the percentage of wound closure at each time
point compared with the original wound area (day 0) is shown.
Accumulated data from 10 individual mice in each group is
expressed as the mean percentage of wound closure ± SEM at
each time point.
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healing period.
WP supplementation during diabetes restores the levels
of wound tissue cytokines
Cytokines are secreted by specific immune cells, carry
signals locally between cells and are critical for the
wound healing process. Therefore, we monitored the
levels of pro- and anti-inflammatory cytokines that con-
trol immune cell function during wound healing in the
three groups of mice. Data from 10 individual mice from
each group are shown in Figure 2. We observed that the
level of pro-inflammatory cytokines (TNF-α, IL-1β and
IL-6) peaked at 4 days post-injury. In diabetic mice, we
observed aberrant and significantly elevated levels of
TNF-α, IL-1β and IL-6 compared with control and WP-
treated diabetic mice from 4 to 13 days post-injury,
which indicates a prolonged pro-inflammatory phase
during the healing of diabetic wounds. By contrast, the
level of IL-10 was significantly reduced in diabetic mice
compared with control and WP-treated diabetic mice at
the same time points. Thus, WP supplementation during
diabetes significantly restored the levels of TNF-α, IL-1β,
IL-6 and IL-10.
The effects of WP supplementation on the expression of
wound tissue chemokines and TGF-β
The expression levels of chemokines and growth factors,
which play important roles in the process of wound
healing, were measured by RT-PCR. Excisional wound
tissues were collected from the 3 groups of mice on days
0, 4, 7, 10 and 13 post-injury. One representativeTable 2 Blood glucose and insulin levels
Blood glucose level (mg/dL)
Control mice Diabetic mice Diabetic +WP
Day 0 120 ± 11 360± 11.7* 280 ± 11.4 + #
Day 7 148 ± 13.8 370± 9.9* 301 ± 10.4 + #
Day 10 129 ± 11.6 345± 8.5* 280 ± 11.2 + #
Day 13 151 ± 12.4 377± 7.9* 257 ± 9.4 + #
Blood insulin level (ng/ml)
Control mice Diabetic mice Diabetic +WP
Day 0 4 ± 0.35 1.1 ± 0.2 2.4 ± 0.22 + #
Day 7 4.5 ± 0.4 1.9 ± 0.18 2.7 ± 0.19 + #
Day 10 3.9 ± 0.33 2.1 ± 0.2 2.2 ± 0.2+
Day 13 5 ± 0.45 1.5 ± 0.12 3 ± 0.25 + #
*P< 0.05 Diabetic vs control.
{ P< 0.005 Diabetic +WP vs control.
# P< 0.05 Diabetic +WP vs diabetic.
The levels of blood glucose and insulin were monitored at the indicated time
points post-injury. Representative results of 10 individual mice from each
group are shown as the mean ± SEM. *P< 0.05, diabetic vs. control; +P< 0.05,
diabetic +WP vs. control; #P< 0.05, diabetic +WP vs. diabetic (ANOVA with
Tukey’s post-test).
Figure 2 Profile of pro- and anti-inflammatory cytokines in
wound area. The levels of pro-inflammatory cytokines (TNF-α, IL-1β
and IL-6) and an anti-inflammatory cytokine (IL-10) were measured
by ELISA in the wound tissues from the 3 groups of mice before
wounding (Day 0) and on the indicated days post-wounding. The
results are expressed as the mean± SEM. *P< 0.05, diabetic vs.
control; +P< 0.05, diabetic +WP vs. control; #P< 0.05, diabetic +WP
vs. diabetic (ANOVA with Tukey’s post-test).
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MIP-2, KC and TGF-β (i.e. one representative experi-
ment for each gene expression (left page) and accumu-
lated data in the bar graphs for each gene represented
(right page) Figure 3. Day 0 represents one hour prior to
wound induction (non-wounded skin tissue). The data
from 10 individual mice from each group reveal that the
levels of MIP-1α, MIP-2 and KC were significantly ele-
vated for a prolonged period in the wound tissue of dia-
betic mice compared with control mice. WP-treated
diabetic mice exhibited partially restored chemokine
levels in wound tissue compared with control and dia-
betic mice (Figure 3 A, B, C). Similarly, the expression
of TGF-β peaked at 4 days post-injury, and in WP-
supplemented diabetic mice, TGF-β levels were signifi-
cantly decreased, especially at days 10 and 13 post-injury,
when compared with diabetic mice (Figure 3 E). By con-
trast, the levels of CX3CL1 were significantly reduced in
diabetic mice when compared with control mice, and sup-
plementation with WP partially restored these levels in dia-
betic mice (Figure 3 D).
Discussion
Although it seems that the role of nutrition is well estab-
lished in immune system functions and inflammatory
diseases, little is known about the role of nutritional sta-
tus in normal physiological processes, such as cutaneous
wound healing [6]. Impaired wound healing in diabetic
patients represents a severe complication of the disease
and, more important, is an ongoing medical problem
associated with significant mortality [31]. Therefore, sev-
eral attempts have been made to understand the under-
lying defects in wound healing. In this study, we
monitored the macroscopic changes and percentage of
wound closure, which reflect the effects of wound con-
traction and healing. We observed that macroscopic
changes and the rate of wound closure were significantly
enhanced in diabetic mice supplemented with WP when
compared with untreated diabetic mice. The accelerated
closure of WP-treated diabetic wounds may be attri-
buted to increased glutathione synthesis and cellular
antioxidant defense [19]. Data obtained during the
optimization of the parameters and conditions of the
animal models during our investigation revealed that
delayed wound repair in diabetic mice was associated
with a significant increase in blood glucose levels and an
obvious decrease in insulin levels, both of which were
reversed by WP supplementation. Similarly, the addition
of whey to meals has been observed to stimulate insulin
release and reduce postprandial blood glucose excursion
after a lunch meal consisting of mashed potatoes and
meatballs in type 2 diabetic subjects [32]. Interestingly,
we observed that WP treatment significantly decreased
the elevated levels of pro-inflammatory cytokines (IL-1β,IL-6, and TNF-α) and increased IL-10 in plasma and
wound tissue. Thus, WP limits prolonged inflammation,
and these data elucidate the mechanism underlying the
enhanced immune response and may be a cause for
improving wound healing in WP-treated diabetic mice.
These results are in agreement with those obtained by
Peranteau et al., [10] who reported that overexpression
of IL-10, an anti-inflammatory cytokine, decreased the
inflammatory response to injury, creating an environ-
ment conducive for regenerative adult wound healing. In
addition, a previous study that supports our results
demonstrated that lactoferrin can regulate the levels of
TNF-α and IL-6, which would decrease inflammation
and mortality [33]. Several studies have focused on the
critical roles of chemokines, such as MIP-1α, MIP2, and
KC, during tissue repair processes [34,35]. In the present
study, treatment of diabetic mice with WP may exert
different effects that obviously increased the expression
of MIP-1α, MIP2, and KC, and these effects may be par-
ticipate in accelerating healing of diabetic wounds. Mori
et al., [29] similarly demonstrated that several chemo-
kines, such as MIP-1α and MIP2, have chemotactic
activities toward neutrophils and macrophages and that
their expression can be upregulated by other pro-
inflammatory cytokines, such as IL-1β. TGF-β plays
an important role in wound repair by adding signals
important for the initiation of the healing cascade and
by attracting macrophages and stimulating them to
secrete additional cytokines, including fibroblast growth
factor (FGF), platelet-derived growth factor (PDGF),
TNF-α and IL-1 [36]. We also observed that WP treat-
ment during diabetes decreased the expression of TGF-β
in the wounded area and may be in turn promoting
wound healing. Previous studies have demonstrated
improvements in wound healing by altering growth fac-
tor and collagen expression [37]. CX3CL1 also contri-
butes to wound healing by recruiting macrophages. In
this study, impaired wound healing in diabetic mice was
accompanied by a significant decrease in the levels of
CX3CL1, which was partially restored by WP supple-
mentation. WP-induced CX3CL1 enhances phagocytosis
and the immune response; thus, WP may be a promising
drug candidate for immunomodulation in chronic dia-
betic wounds. This study suggests that the oral adminis-
tration of camel WP may be a new avenue for the
treatment of skin wounds in diabetic patients.
Conclusions
Taken together, the data presented in this study
expand our knowledge of the benefits of WP supple-
mentation in improving the healing and closure of dia-
betic wounds, suggesting that WP may be a promising
drug candidate for treating diabetic wounds and their
associated complications.
Figure 3 Analysis of inflammatory chemokines, CX3CL1 and TGF-β1 in wound tissues. Inflammatory chemokines, CX3CL1 and TGF-β1 were
detected in non-wounded (Day 0) and wounded (4, 7, 10 and 13 days) skin of the same animals in the 3 groups of mice. (A-E) Representative
RT-PCR results from three independent experiments with three animals per group are shown. (B) The ratios of RT-PCR signals for the indicated
effectors to β-actin were calculated. Values represent the mean± SEM. *P< 0.05, diabetic vs. control; +P< 0.05, diabetic +WP vs. control; #P< 0.05,
diabetic +WP vs. diabetic (ANOVA with Tukey’s post-test).
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